Expression of LC3 in OLs was significantly increased in the MS cases, both in the chronic active lesions and in normal appearing white matter (NAWM), compared to control tissue samples from non-MS cases (Fig. 2b). Here, MAP1LC3A is linked to myeloid sarcoma.